Pilot Study Evaluating the Impact of Stress Reduction on Atherosclerotic : Heart and Mind Study
NCT04496947
This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .
Summary
The plot study aims to evaluate the effect of 8 weeks of stress reducing intervention on atherosclerotic plaque inflammation in adults, as quantified by positron emission tomography (PET) with fluorine-2-deoxy-D-glucose (FDG) in individuals with increased psychosocial stress.
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Atherosclerosis
- Stress
- Inflammation
Eligibility basics and study details
- Study type
- Interventional
- Phase
- Not applicable
- Ages
- 30 to 65 years
- Sex
- All
- Healthy volunteers
- Accepted
- Sponsor
- Massachusetts General Hospital
- Last updated on ClinicalTrials.gov
- June 3, 2026
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
Massachusetts · 1
- Massachusetts General Hospital · Boston, MA
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.